Table 4.

Predictors of Cancer Specific Mortality

Factor	Overall Mortality HR* (95% CI)
Trial Enrollment
Enrolled vs Not Enrolled	0.74 (0.66–0.83)
Gender
Female vs Male	0.86 (0.85–0.87)
Marital Status
Married vs Single	0.88 (0.87–0.89)
Divorced/Separated/Widowed vs Single	1.06 (1.04–1.08)
Unknown vs Single	0.71 (0.69–0.74)
Race
Non-Hispanic Blacks vs Non-Hispanic White	1.03 (1.01–1.05)
Hispanic vs Non-Hispanic White	0.93 (0.91–0.94)
Asian/Pacific Islander vs Non-Hispanic White	0.81 (0.79–0.82)
American Indian vs Non-Hispanic White	1.07 (0.99–1.15)
Unknown vs Non-Hispanic White	0.39 (0.36–0.43)
Payer
Underinsured vs Private	1.11 (1.10–1.13)
Military vs Private	1.12 (1.06–1.18)
Uninsured vs Private	1.15 (1.11–1.19)
Grade
High vs Low Grade	1.55 (1.53–1.57)
Unassessed vs Low Grade	1.29 (1.27–1.30)
CoC Hospital
CoC Approved vs Not Approved	0.92 (0.91–0.93)
Unknown vs Not Approved	1.09 (1.04–1.13)
Stage
I vs IV	0.16 (0.15–0.16)
II vs IV	0.32 (0.31–0.32)
III vs IV	0.55 (0.54–0.56)
Unknown vs IV	0.47 (0.46–0.47)
Residence
Rural vs Urban	1.02 (1.00–1.031)

^*Adjusted for age, year of diagnosis, organ site, tumor grade, and treatment modalities received.